FTC joins DOJ in rescinding healthcare antitrust guidance
By 
Kyle Brasseur2023-07-17T14:37:00
The Federal Trade Commission (FTC) announced the withdrawal of two antitrust policy statements the agency deemed “outdated.”
The decision targets guidance on antitrust enforcement in healthcare published in August 1996 and on accountable care organizations published in October 2011. The move puts the FTC in line with the Department of Justice, which similarly withdrew its guidance on each matter earlier this year.
“Given the profound changes in these markets over the last 30 years, the statements no longer serve their intended purpose of providing accurate guidance to market participants,” said the FTC in a press release Friday. “Rather, the commission’s extensive record of enforcement actions, policy statements, and competition advocacy in healthcare provide more up-to-date guidance to the public.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
PremiumDOJ official: Aspects of healthcare competition ‘broken’; antitrust enforcement can help
It’s no secret the U.S. healthcare competition system has significant flaws. Where the debate exists is in determining the source of the issues and how to fix them, according to Deputy Assistant Attorney General Andrew Forman of the Department of Justice’s Antitrust Division.
-
PremiumM&A lessons from EU’s maximum $476M fine against Illumina
The European Commission imposed maximum disciplinary measures in fining U.S.-based biotechnology company Illumina €432 million (U.S. $476 million) regarding its “gun-jumping” merger with cancer detection company Grail.
-
News Brief
Five more board members resign in DOJ antitrust sweep
Five corporate board members resigned after being flagged by the Department of Justice for potentially violating the antitrust provisions of the Clayton Act.
More from Regulatory Policy
-
ArticleSEC gets earful about disclosure requirements from investors
Disclosure requirements for public companies have ballooned over the decades and need to be reigned in, the three members of the Securities and Exchange Commission (SEC), said Thursday.
-
ArticleNew DOJ policy places corporate enforcement emphasis on individual misconduct
The Department of Justice (DOJ) criminal division has announced a blanket policy against prosecuting companies that voluntarily disclose criminal wrongdoing and take other steps—and holding any individuals involved accountable for their criminal activities.
-
ArticleIf financial services firms don’t want more AI rules, comply with existing regs, experts warn
The U.K.’s financial regulators have long maintained that AI use by banks, insurers, and other financial services firms is already regulated under existing rules, but such assurances are increasingly being questioned.